In humans, increased expression of MIF has been linked to pathogenesis in inflammatory conditions across organ systems, including atherosclerosis, asthma, cystic fibrosis, IBD, nephrotic syndrome, multiple sclerosis, rheumatoid arthritis, and lupus [54,55,56,57]. This evidence concerns the gene MIF and systemic lupus erythematosus.